Hjem › Ikke-småcellet lungekreft › Illinois › Waukegan
Kliniske studier for Ikke-småcellet lungekreft i Waukegan, IL
16 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Waukegan (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekruttererFase 3
- Cancer Treatment Centers of America (CTCA), Zion · 6 mi unna
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruttererFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi unna
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi unna
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- Condell Memorial Hospital, Libertyville · 8 mi unna
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekruttererFase 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8 mi unna
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 2
- City of Hope Chicago, Zion · 6 mi unna
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruttererFase 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3 mi unna
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekruttererFase 3
- Research Site, Zion · 6 mi unna
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekruttererFase 3
- Research Site, North Chicago · 3 mi unna
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekruttererFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi unna
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- Condell Memorial Hospital, Libertyville · 8 mi unna
- og 1 flere
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- Condell Memorial Hospital, Libertyville · 8 mi unna
- og 1 flere
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- Condell Memorial Hospital, Libertyville · 8 mi unna
- og 1 flere
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi unna
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
RekruttererFase 2
- City of Hope at Chicago, Zion · 6 mi unna
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- Condell Memorial Hospital, Libertyville · 8 mi unna
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Waukegan
- Lungekreft16 studier
- Brystkreft12 studier
- Ulcerøs kolitt7 studier
- Nyrekreft (nyrecellekarcinom)7 studier
- Metastatisk kreft6 studier
- Prostatakreft6 studier
- Plateepitelcancer i hode og hals6 studier
- Kolorektal kreft6 studier
- Eggstokkreft6 studier
- Melanom5 studier
- Crohns sykdom5 studier
- Akut myelogen leukemi5 studier
Fra ClinicalTrials.gov, data hentet 7. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.